Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients

Wilfried De Backer, Wim Vos, Cedric Van Holsbeke, Samir Vinchurkar, Rita Claes, Annemie Hufkens, Paul M. Parizel, Lieven Bedert, Jan De Backer
European Respiratory Journal 2014; DOI: 10.1183/09031936.00011714
Wilfried De Backer
1Dept of Respiratory Medicine, University Hospital Antwerp, Antwerp, Belgium,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Jan.DeBacker@Fluidda.com
Wim Vos
2Fluidda nv, Kontich, Belgium,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cedric Van Holsbeke
2Fluidda nv, Kontich, Belgium,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samir Vinchurkar
2Fluidda nv, Kontich, Belgium,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rita Claes
1Dept of Respiratory Medicine, University Hospital Antwerp, Antwerp, Belgium,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annemie Hufkens
1Dept of Respiratory Medicine, University Hospital Antwerp, Antwerp, Belgium,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul M. Parizel
3Dept of Radiology, University Hospital Antwerp, Antwerp, Belgium,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lieven Bedert
4Dept of Respiratory Medicine, ZNA Middelheim Hospital, Antwerp, Belgium,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan De Backer
2Fluidda nv, Kontich, Belgium,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Jan.DeBacker@Fluidda.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

COPD patients prone to dynamic hyperinflation tend to benefit from roflumilast due to change in airflow distribution http://ow.ly/v6S0O

  • Received January 15, 2014.
  • Accepted March 12, 2014.
  • © ERS
Next
Back to top
Vol 61 Issue 4 Table of Contents
European Respiratory Journal: 61 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients
Wilfried De Backer, Wim Vos, Cedric Van Holsbeke, Samir Vinchurkar, Rita Claes, Annemie Hufkens, Paul M. Parizel, Lieven Bedert, Jan De Backer
European Respiratory Journal Jan 2014, erj00117-2014; DOI: 10.1183/09031936.00011714

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients
Wilfried De Backer, Wim Vos, Cedric Van Holsbeke, Samir Vinchurkar, Rita Claes, Annemie Hufkens, Paul M. Parizel, Lieven Bedert, Jan De Backer
European Respiratory Journal Jan 2014, erj00117-2014; DOI: 10.1183/09031936.00011714
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • A rare pulmonary zygomycosis manifested as chronic mediastinitis and bronchial perforation
  • Pulmonary endarterectomy in sickle cell haemoglobin C disease
  • Cell count and lymphocyte immunophenotyping of bronchoalveolar lavage fluid in healthy Brazilian children
Show more Letter

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society